Corden Pharma Brussels
The KBO register records legal situation 012 for Corden Pharma Brussels (Register: dissolution or liquidation); this is today's state according to the register itself, which carries no start date. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 39 yrs |
| Board | 11 |
| Locations | 1 |
| Publications | 21 |
Dissolution or liquidation
The KBO register records that this company is being wound up. A twelve-month bankruptcy probability no longer says anything in that case, so we show no figure.
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 24-09-2025 | 2025-00502570 |
| 31-12-2023 | volledig | 30-10-2024 | 2024-00525188 |
| 31-12-2022 | volledig | 27-07-2023 | 2023-00297444 |
| 31-12-2021 | volledig | 28-06-2022 | 2022-20108455 |
| 31-12-2020 | volledig | 21-06-2021 | 2021-22000285 |
| 31-12-2019 | volledig | 28-07-2020 | 2020-34900585 |
| 31-12-2018 | volledig | 14-10-2019 | 2019-70100551 |
| 31-12-2017 | volledig | 13-06-2018 | 2018-17900569 |
| 31-12-2016 | volledig | 27-06-2017 | 2017-22500277 |
| 31-12-2015 | volledig | 29-06-2016 | 2016-26100388 |
-
Wim HeethemLiquidatorState Gazette act 25049931 (16-04-2025)Current16-04-2025 → present
-
Lee NewtonDirectorState Gazette act 23158531 (12-12-2023)Current12-12-2023 → present
-
Naoki TakeiDirectorState Gazette act 23158531 (12-12-2023)Current12-12-2023 → present
-
Didier DelanoyeAuditorState Gazette act 23114848 (07-09-2023)Current07-09-2023 → present
-
PwC Reviseurs d'Entreprises SRLLegal entityAuditorState Gazette act 23114848 (07-09-2023)Current07-09-2023 → present
-
Céderic DevroeyMandataire spécialState Gazette act 22003983 (07-01-2022)Current07-01-2022 → present
Show 5 more sitting directors
-
Gisèle RosselleMandataire spécialState Gazette act 22003983 (07-01-2022)Current07-01-2022 → present
-
Marie-Elisabeth DuboisMandataire spécialState Gazette act 22003983 (07-01-2022)Current07-01-2022 → present
-
Thijs KeuleersMandataire spécialState Gazette act 22003983 (07-01-2022)Current07-01-2022 → present
-
Jean-Luc DewezAdministrator uniqueState Gazette act 22009795 (24-01-2022)Current02-06-2021 → present
3 events
- 24-01-2022 Appointed· Administrator unique
- 02-06-2021 Appointed· Director
- 02-06-2021 Appointed· Managing director
-
Martin LeitgebDirectorState Gazette act 20095082 (20-08-2020)Current05-06-2020 → present
3 events
- 24-01-2022 Resigned· Administrator
- 20-08-2020 Appointed· Director
- 05-06-2020 Appointed· Director
Historic, not recently confirmed (1)
-
Yves MichonDirectorState Gazette act 20056476 (11-05-2020)Not recently confirmedlast confirmed in an act from 2020
6 events
- 11-05-2020 Appointed· Director
- 20-03-2020 Appointed· Director
- 10-01-2019 Resigned· Daily management delegate
- 01-10-2018 Appointed· Managing director
- 11-06-2018 Appointed· Director
- 11-06-2018 Appointed· Président du conseil d'administration
Former directors (8)
-
MICHON Yves JeanAdministratorState Gazette act 22009795 (24-01-2022)Former- → 24-01-2022
-
Riku RautsolaDirectorState Gazette act 20056476 (11-05-2020)Former20-03-2020 → 02-06-2021
3 events
- 02-06-2021 Resigned· Director
- 11-05-2020 Appointed· Director
- 20-03-2020 Appointed· Director
-
Jan BraesDirectorState Gazette act 19005198 (10-01-2019)Former10-01-2019 → 05-06-2020
4 events
- 05-06-2020 Resigned· Managing director
- 11-05-2020 Resigned· Managing director
- 10-01-2019 Appointed· Director
- 10-01-2019 Appointed· Daily management delegate
-
Marc NewDirectorState Gazette act 20042740 (20-03-2020)Former- → 20-03-2020
-
Robert LangmantelDirectorState Gazette act 18144759 (01-10-2018)Former01-10-2018 → 10-01-2019
2 events
- 10-01-2019 Resigned· Director
- 01-10-2018 Appointed· Director
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Robert SnijkersCurrent Commissaire |
- | 20-08-2020 → present |
Show 1 earlier auditors
| KPMG - Réviseurs d'entreprises SCRL Commissaire succeeded by Robert Snijkers in 2020 |
- | 11-06-2018 → 20-08-2020 |
| NACE primary | Vervaardiging van farmaceutische grondstoffen(21100) |
| Legal form | Public limited company(014) |
| Incorporation | 09-04-1987 |
| Status | Active |
| Postal code | 1050 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21822R0226/00W011 | Brussels | 3,529 m² | 1 · 1,878 m² | 38.1 m · 7 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 38 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
29-04-2025 Registered office moved from Bruxelles to Ixelles
- Rue de Ransbeek 310, 1120 Bruxelles → Avenue Louise 523, 1050 Ixelles
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Avenue Louise 523, 1050 Ixelles",
"city": "Ixelles",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Avenue Louise",
"country": "BE",
"postcode": "1050",
"box_number": null,
"street_number": "523",
"locality_suffix": null
},
"old_address": {
"raw": "Rue de Ransbeek 310, 1120 Bruxelles",
"city": "Bruxelles",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Rue de Ransbeek",
"country": "BE",
"postcode": "1120",
"box_number": null,
"street_number": "310",
"locality_suffix": null
},
"effective_date": "2025-03-27",
"evidence_quote": "Le conseil d\u0027administration a d\u00E9cid\u00E9 de transf\u00E9rer le si\u00E8ge de la soci\u00E9t\u00E9, ainsi que l\u0027adresse de l\u0027unit\u00E9 d\u0027\u00E9tablissement de la soci\u00E9t\u00E9, de Rue de Ransbeek 310, 1120 Bruxelles \u00E0 Avenue Louise 523, 1050 Ixelles avec effet au 27 mars 2025.",
"region_changed": false,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Yves Lenders",
"firm_city": null,
"firm_name": "Lydian SRL",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2025-04-29",
"filing_date": "2025-03-27",
"act_kind_objet": "Objet de l\u0027acte: Transfert du si\u00E8ge"
},
"decision": {
"body": "raad_van_bestuur",
"date": "2025-03-27",
"unanimous": true
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "Corden Pharma Brussels",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Maxine Daems",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire"
},
"co_filed_documents": [
"Extrait des d\u00E9cisions \u00E9crites unanimes du conseil d\u0027administration du 27 mars 2025",
"Procuration sp\u00E9ciale \u00E0 Monsieur Yves Lenders, Monsieur Luc Germonpr\u00E9 et Madame Maxine Daems"
]
}16-04-2025 Dissolution with immediate closure of the liquidation
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"end_event": {
"sub_type": "voluntary_dissolution_with_close",
"liquidator": {
"name": "Wim Heethem"
}
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "Corden Pharma Brussels"
}
}12-12-2023 2 directors appointed
- Lee Newton, Bestuurder
- Naoki Takei, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Lee Newton",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Naoki Takei",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "Corden Pharma Brussels"
}
}07-09-2023 2 directors appointed
- PwC Reviseurs d'Entreprises SRL, Auditor
- Didier Delanoye, Auditor
Technical details
{
"events": [
{
"kind": "director_in",
"role": "auditor",
"person": {
"rrn": null,
"name": "PwC Reviseurs d\u0027Entreprises SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "auditor",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "Corden Pharma Brussels"
}
}24-01-2022 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "CORDEN PHARMA BRUSSELS"
},
"legal_form_change": {
"new": "soci\u00E9t\u00E9 anonyme",
"old": "soci\u00E9t\u00E9 anonyme",
"changed": false
}
}07-01-2022 4 directors appointed
- Gisèle Rosselle, Mandataire spécial
- Céderic Devroey, Mandataire spécial
- Thijs Keuleers, Mandataire spécial
- Marie-Elisabeth Dubois, Mandataire spécial
Technical details
{
"events": [
{
"kind": "director_in",
"role": "mandataire sp\u00E9cial",
"person": {
"rrn": null,
"name": "Gis\u00E8le Rosselle",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "mandataire sp\u00E9cial",
"person": {
"rrn": null,
"name": "C\u00E9deric Devroey",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "mandataire sp\u00E9cial",
"person": {
"rrn": null,
"name": "Thijs Keuleers",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "mandataire sp\u00E9cial",
"person": {
"rrn": null,
"name": "Marie-Elisabeth Dubois",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "CORDEN PHARMA BRUSSELS"
}
}09-11-2021 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Alexandre Claeys",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": null,
"filing_date": "2021-10-28",
"act_kind_objet": "D\u00E9p\u00F4t conform\u00E9ment \u00E0 l\u0027article 7:231, al.1 CSA"
},
"decision": {
"body": "notarieel_alleen",
"act_date": "2021-07-15",
"unanimous": null
},
"conversion": null,
"detected_kind": "court_filing_notice",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0430.891.915",
"name": "CORDEN PHARMA BRUSSELS",
"role": "other",
"address": "Rue de Ransbeek 310, 1120 Neder-over-Heembeek",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"7:231"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": "La d\u00E9claration de la soci\u00E9t\u00E9 dat\u00E9e du 15 juillet 2021 est d\u00E9pos\u00E9e au greffe du Tribunal de l\u0027Entreprise de Bruxelles, conform\u00E9ment \u00E0 l\u0027article 7:231, al.1 CSA.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "CORDEN PHARMA BRUSSELS",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Alexandre Claeys",
"org_rep_person_name": null
},
"summary_narrative": "La soci\u00E9t\u00E9 CORDEN PHARMA BRUSSELS SA a d\u00E9pos\u00E9 sa d\u00E9claration du 15 juillet 2021 au greffe du Tribunal de l\u0027Entreprise de Bruxelles, conform\u00E9ment \u00E0 l\u0027article 7:231, al.1 CSA. Alexandre Claeys, administrateur de Verbanck, Plas \u0026 Partners SRL, a \u00E9t\u00E9 mandat\u00E9 pour effectuer ce d\u00E9p\u00F4t et toutes les formalit\u00E9s n\u00E9cessaires \u00E0 la publication au Moniteur belge.",
"co_filed_documents": [],
"detected_real_type": "court_filing_notice",
"referenced_correction": null,
"should_reroute_to_category": null
}10-09-2021 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": true
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "Corden Pharma Brussels"
},
"legal_form_change": {
"new": "soci\u00E9t\u00E9 anonyme",
"old": "soci\u00E9t\u00E9 anonyme",
"changed": false
}
}02-06-2021 2 directors appointed, 1 resigning
- Jean-Luc Dewez, Bestuurder
- Jean-Luc Dewez, Gedelegeerd bestuurder
- Riku Rautsola, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Riku Rautsola",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jean-Luc Dewez",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Jean-Luc Dewez",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "CORDEN PHARMA BRUSSELS"
}
}20-08-2020 3 directors appointed
- Martin Leitgeb, Bestuurder
- Robert Snijkers, Commissaire
- KPMG - Réviseurs d'entreprises SCRL, Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Martin Leitgeb",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Robert Snijkers",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "KPMG - R\u00E9viseurs d\u0027entreprises SCRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "CORDEN PHARMA BRUSSELS"
}
}05-06-2020 1 director appointed, 1 resigning
- Martin Leitgeb, Bestuurder
- Jan Braes, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Jan Braes",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Martin Leitgeb",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "Corden Pharma Brussels"
}
}11-05-2020 2 directors appointed, 1 resigning
- Yves Michon, Bestuurder
- Riku Rautsola, Bestuurder
- Jan Braes, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Jan Braes",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Yves Michon",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Riku Rautsola",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "Corden Pharma Brussels"
}
}20-03-2020 2 directors appointed, 1 resigning
- Riku Rautsola, Bestuurder
- Yves Michon, Bestuurder
- Marc New, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Marc New",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Riku Rautsola",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Yves Michon",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "Corden Pharma Brussels"
}
}10-01-2019 2 directors appointed, 2 resigning
- Jan Braes, Bestuurder
- Jan Braes, Dagelijks bestuur
- Robert Langmantel, Bestuurder
- Yves Michon, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jan Braes",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Robert Langmantel",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Yves Michon",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Jan Braes",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "Corden Pharma Brussels"
}
}01-10-2018 2 directors appointed, 1 resigning
- Robert Langmantel, Bestuurder
- Yves Michon, Gedelegeerd bestuurder
- Patrice Locht, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Patrice Locht",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Robert Langmantel",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Yves Michon",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "Corden Pharma Bruxelles"
}
}11-06-2018 3 directors appointed, 2 resigning
- KPMG - Réviseurs d'entreprises SCRL, Commissaire
- Yves Michon, Bestuurder
- Yves Michon, Président du conseil d'administration
- Christian Ewers, Bestuurder
- Christian Ewers, Président du conseil d'administration
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "KPMG - R\u00E9viseurs d\u0027entreprises SCRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Christian Ewers",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Yves Michon",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "pr\u00E9sident du conseil d\u0027administration",
"person": {
"rrn": null,
"name": "Christian Ewers",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "pr\u00E9sident du conseil d\u0027administration",
"person": {
"rrn": null,
"name": "Yves Michon",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "Corden Pharma Brussels"
}
}21-09-2016 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "Corden Pharma Brussels",
"old": "PEPTISYNTHA",
"changed": true
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "PEPTISYNTHA"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 Anonyme",
"old": "Soci\u00E9t\u00E9 Anonyme",
"changed": false
}
}03-03-2016 Capital increase of €1,000,000 to €11,259,900
- €10.259.900 → €11.259.900
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 11259900,
"delta_eur": 1000000,
"before_eur": 10259900,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "PEPTISYNTHA"
}
}04-01-2016 1 director appointed, 1 resigning
- Patrice Locht, Gedelegeerd bestuurder
- Becap BVBA, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Becap BVBA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Patrice Locht",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "PEPTISYNTHA"
}
}22-09-2015 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "PEPTISYNTHA"
},
"legal_form_change": {
"new": "",
"old": "SOCIETE ANONYME",
"changed": false
}
}02-09-2015 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0430.891.915",
"name_full": "PEPTISYNTHA"
},
"legal_form_change": {
"new": "",
"old": "SOCI\u00C9T\u00C9 ANONYME",
"changed": false
}
}| Legal name | Corden Pharma Brussels |